Regeneron Selects Veeva Vault CRM Globally
Veeva Systems announced in a press release that Regeneron Pharmaceuticals has committed to Veeva Vault CRM globally.
Regeneron plans to use Vault CRM to generate Commercial Evidence from AI powered field engagement. The system is designed to capture information from field interactions, including barriers to treatment adoption.
Vault CRM is part of the Veeva Vault CRM Suite for commercial execution in life sciences. Its Agentic Call Report feature records field interaction insights that Veeva says may otherwise be missed in structured forms.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Sep 11 Evergreen Digital Media Invests in Adwave and Licenses AI Ad Platform Sep 11 Rime to Power Dialpad Voice AI Products Sep 11 Ultima Genomics and NVIDIA Collaborate on Pangenome Sequencing Analysis Sep 11 Zettabyte and Raku Plan Renewable Energy AI Data Centers in Asia Sep 11 DCM Services and AKUVO Partner on Estate RecoveryMore from Life Sciences
Sep 12 Aignostics Opens Early Access to PathoSearch Sep 11 Ultima Genomics and NVIDIA Collaborate on Pangenome Sequencing Analysis Sep 11 UrgentIQ Raises $15 Million for AI Clinical Workflows Sep 11 Penguin Ai Launches Revenue Cycle AI Platform Sep 11 MegazoneCloud Builds Quality Assurance AI Agent for Hanmi PharmaceuticalLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
BioVid Launches Tumor Worlds for Oncology Market Intelligence
Burke and Verve Partner on AI Decision Intelligence Systems
Vital Records Control Acquires AskTuring.ai
Authenticx Adds Form Automation and Routing to Safety AI
PharmaForceIQ Launches Optichannel 360 for Pharma Commercial Teams
Daily AI Brief: the AI news that matters, in your inbox.